PBLA
Closed
Panbela Therapeutics Inc
0.165
-0.067 (-28.88%)
Last Update: 01 Jul 2025 19:15:00
Yesterday: 0.232
Day's Range: 0.165 - 0.226
Send
sign up or login to leave a comment!
When Written:
0.3551
Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on developing innovative cancer therapies. The company's lead product candidate, SBP-101, is a first-in-class, proprietary, injectable drug that is being developed for the treatment of pancreatic cancer. SBP-101 has been granted orphan drug designation by the US FDA and has shown promising results in preclinical and early clinical studies.
Panbela Therapeutics was founded in 2017 and is headquartered in New York City. The company's management team has extensive experience in the biopharmaceutical industry, including in drug development, clinical research, and commercialization. Panbela Therapeutics has partnerships with leading academic institutions and research organizations to advance its drug development programs.
The company's mission is to improve the lives of cancer patients by developing innovative therapies that target unmet medical needs. Panbela Therapeutics is committed to advancing its pipeline of cancer therapeutics and bringing new treatment options to patients with cancer.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Panbela Therapeutics was founded in 2017 and is headquartered in New York City. The company's management team has extensive experience in the biopharmaceutical industry, including in drug development, clinical research, and commercialization. Panbela Therapeutics has partnerships with leading academic institutions and research organizations to advance its drug development programs.
The company's mission is to improve the lives of cancer patients by developing innovative therapies that target unmet medical needs. Panbela Therapeutics is committed to advancing its pipeline of cancer therapeutics and bringing new treatment options to patients with cancer.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








